These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 12517782

  • 1. Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice.
    Pastorino F, Brignole C, Marimpietri D, Sapra P, Moase EH, Allen TM, Ponzoni M.
    Cancer Res; 2003 Jan 01; 63(1):86-92. PubMed ID: 12517782
    [Abstract] [Full Text] [Related]

  • 2. Development of Fab' fragments of anti-GD(2) immunoliposomes entrapping doxorubicin for experimental therapy of human neuroblastoma.
    Brignole C, Marimpietri D, Gambini C, Allen TM, Ponzoni M, Pastorino F.
    Cancer Lett; 2003 Jul 18; 197(1-2):199-204. PubMed ID: 12880982
    [Abstract] [Full Text] [Related]

  • 3. Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.
    Cheng WW, Allen TM.
    J Control Release; 2008 Feb 18; 126(1):50-8. PubMed ID: 18068849
    [Abstract] [Full Text] [Related]

  • 4. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
    Hatakeyama H, Akita H, Ishida E, Hashimoto K, Kobayashi H, Aoki T, Yasuda J, Obata K, Kikuchi H, Ishida T, Kiwada H, Harashima H.
    Int J Pharm; 2007 Sep 05; 342(1-2):194-200. PubMed ID: 17583453
    [Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
    Lopes de Menezes DE, Pilarski LM, Allen TM.
    Cancer Res; 1998 Aug 01; 58(15):3320-30. PubMed ID: 9699662
    [Abstract] [Full Text] [Related]

  • 6. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
    Sugano M, Egilmez NK, Yokota SJ, Chen FA, Harding J, Huang SK, Bankert RB.
    Cancer Res; 2000 Dec 15; 60(24):6942-9. PubMed ID: 11156394
    [Abstract] [Full Text] [Related]

  • 7. Improved therapeutic responses in a xenograft model of human B lymphoma (Namalwa) for liposomal vincristine versus liposomal doxorubicin targeted via anti-CD19 IgG2a or Fab' fragments.
    Sapra P, Moase EH, Ma J, Allen TM.
    Clin Cancer Res; 2004 Feb 01; 10(3):1100-11. PubMed ID: 14871990
    [Abstract] [Full Text] [Related]

  • 8. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
    Pastorino F, Brignole C, Marimpietri D, Pagnan G, Morando A, Ribatti D, Semple SC, Gambini C, Allen TM, Ponzoni M.
    Clin Cancer Res; 2003 Oct 01; 9(12):4595-605. PubMed ID: 14555535
    [Abstract] [Full Text] [Related]

  • 9. Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma.
    Loi M, Marchiò S, Becherini P, Di Paolo D, Soster M, Curnis F, Brignole C, Pagnan G, Perri P, Caffa I, Longhi R, Nico B, Bussolino F, Gambini C, Ribatti D, Cilli M, Arap W, Pasqualini R, Allen TM, Corti A, Ponzoni M, Pastorino F.
    J Control Release; 2010 Jul 01; 145(1):66-73. PubMed ID: 20346382
    [Abstract] [Full Text] [Related]

  • 10. Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy.
    Pastorino F, Brignole C, Di Paolo D, Nico B, Pezzolo A, Marimpietri D, Pagnan G, Piccardi F, Cilli M, Longhi R, Ribatti D, Corti A, Allen TM, Ponzoni M.
    Cancer Res; 2006 Oct 15; 66(20):10073-82. PubMed ID: 17047071
    [Abstract] [Full Text] [Related]

  • 11. Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.
    Pastorino F, Brignole C, Marimpietri D, Cilli M, Gambini C, Ribatti D, Longhi R, Allen TM, Corti A, Ponzoni M.
    Cancer Res; 2003 Nov 01; 63(21):7400-9. PubMed ID: 14612539
    [Abstract] [Full Text] [Related]

  • 12. Increase of therapeutic effects by treating melanoma with targeted combinations of c-myc antisense and doxorubicin.
    Pastorino F, Mumbengegwi DR, Ribatti D, Ponzoni M, Allen TM.
    J Control Release; 2008 Feb 18; 126(1):85-94. PubMed ID: 18166243
    [Abstract] [Full Text] [Related]

  • 13. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
    Kirpotin D, Park JW, Hong K, Zalipsky S, Li WL, Carter P, Benz CC, Papahadjopoulos D.
    Biochemistry; 1997 Jan 07; 36(1):66-75. PubMed ID: 8993319
    [Abstract] [Full Text] [Related]

  • 14. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A, Bergeron MG.
    Methods Enzymol; 2005 Jan 07; 391():330-51. PubMed ID: 15721390
    [Abstract] [Full Text] [Related]

  • 15. Cellular association and cytotoxicity of doxorubicin-loaded immunoliposomes targeted via Fab' fragments of an anti-CD74 antibody.
    Lundberg BB, Griffiths G, Hansen HJ.
    Drug Deliv; 2007 Mar 07; 14(3):171-5. PubMed ID: 17454037
    [Abstract] [Full Text] [Related]

  • 16. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
    Park JW, Hong K, Kirpotin DB, Colbern G, Shalaby R, Baselga J, Shao Y, Nielsen UB, Marks JD, Moore D, Papahadjopoulos D, Benz CC.
    Clin Cancer Res; 2002 Apr 07; 8(4):1172-81. PubMed ID: 11948130
    [Abstract] [Full Text] [Related]

  • 17. In vitro efficacy of a sterically stabilized immunoliposomes targeted to membrane type 1 matrix metalloproteinase (MT1-MMP).
    Atobe K, Ishida T, Ishida E, Hashimoto K, Kobayashi H, Yasuda J, Aoki T, Obata K, Kikuchi H, Akita H, Asai T, Harashima H, Oku N, Kiwada H.
    Biol Pharm Bull; 2007 May 07; 30(5):972-8. PubMed ID: 17473445
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo antitumor activity of liposomal Fenretinide targeted to human neuroblastoma.
    Raffaghello L, Pagnan G, Pastorino F, Cosimo E, Brignole C, Marimpietri D, Montaldo PG, Gambini C, Allen TM, Bogenmann E, Ponzoni M.
    Int J Cancer; 2003 May 01; 104(5):559-67. PubMed ID: 12594810
    [Abstract] [Full Text] [Related]

  • 19. Cytotoxicity of adriamycin-containing immunoliposomes targeted with anti-ganglioside monoclonal antibodies.
    Ohta S, Igarashi S, Honda A, Sato S, Hanai N.
    Anticancer Res; 1993 May 01; 13(2):331-6. PubMed ID: 8517645
    [Abstract] [Full Text] [Related]

  • 20. In vivo targeting of OV-TL 3 immunoliposomes to ascitic ovarian carcinoma cells (OVCAR-3) in athymic nude mice.
    Nässander UK, Steerenberg PA, Poppe H, Storm G, Poels LG, De Jong WH, Crommelin DJ.
    Cancer Res; 1992 Feb 01; 52(3):646-53. PubMed ID: 1732053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.